Skip to Main

Search

Results 271 to 280 of 935 for ""

Common weight-loss drug successfully targets fat that can endanger heart health: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/obesity-drug.html

Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide.

Patient's satisfaction with doctor could influence decision to have bariatric surgery: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/february-bariatric-surgery.html

Patients’ satisfaction with their physicians may influence their decisions to undergo bariatric surgery, according to a multicenter study.

UT Southwestern researchers use AI to detect new family of genes in gut bacteria : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/june-gut-bacteria.html

Using artificial intelligence, UT Southwestern researchers have discovered a new family of sensing genes in enteric bacteria that are linked by structure and probably function, but not genetic sequence.

Fighting inflammatory bowel disease at its source: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/fighting-ibd.html

New findings on mechanism for intestinal inflammation could offer new targets for treating ulcerative colitis, Crohn’s disease, and other conditions

Fighting intestinal infections with the body's own endocannabinoids: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/fighting-intestinal-infections.html

Endocannabinoids, signaling molecules produced in the body that share features with chemicals found in marijuana, can shut down genes needed for some pathogenic intestinal bacteria to colonize, multiply, and cause disease, new research led by UT Southwestern scientists shows.

UTSW researchers reveal how frameshifting is key to SARS-CoV-2 replication : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/sept-sars-cov-2-replication.html

Researchers at UT Southwestern Medical Center discovered how the virus responsible for COVID-19 harnesses a feature of its host cells to read its genetic code twice.

Preoperative immunotherapy could enhance breast cancer cure rates: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/feb-preoperative-immunotherapy.html

A phase three clinical trial co-led by a researcher at UT Southwestern Harold C. Simmons Comprehensive Cancer Center showcases the promise of administering immunotherapy along with chemotherapy before surgery in patients with breast cancer at high risk of spreading. The findings, published in Nature

AI tool helps identify heart failure risk in diabetes patients: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/oct-diabetic-cardiomyopathy.html

Researchers at UT Southwestern Medical Center have developed a machine learning model that can identify patients with diabetic cardiomyopathy, a heart condition characterized by abnormal changes in the heart’s structure and function that predisposes them to increased risk of heart failure.

Daniel Siegwart, Ph.D., named fellow of the National Academy of Inventors: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-siegwart-nai.html

Daniel Siegwart, Ph.D., Professor in the Departments of Biomedical Engineering and Biochemistry and in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, has been selected as a fellow of the National Academy of Inventors (NAI) in recognition of his efforts in

Patient Notification: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-media-statement.html

UT Southwestern Medical Center is notifying individuals whose data may have been inappropriately disclosed; however, UT Southwestern has received no indication that the information has been used inappropriately.